Integer Holdings, a Plano-based medical device contract development and manufacturing organization, is selling its Electrochem business, which focuses on non-medical applications for the energy, military, and environmental sectors, to Ultralife Corp. for $50 million in cash.
The deal—which follows the news of Integer’s recent $60 million and $30 million manufacturing expansions in Ireland—is expected to close by the end of October.
“The divestiture of our non-medical business is another example of Integer managing our portfolio to accomplish our strategic financial objectives,” Joe Dziedzic, Integer’s president & CEO, said in a statement. “Following the transaction, Integer will be a pure-play medical business with additional cash to pay down debt and execute our inorganic growth strategy.:
“Ultralife is an ideal buyer for Electrochem because they are a leader in providing critical power solutions to a variety of industries that include energy, defense, and environmental markets,” Dziedzic added.
Going forward, Integer will report the results of its Electrochem business, currently included in its “Non-Medical” segment, as part of discontinued operations, the company said. This will include any gain or loss recognized on the sale of the business.
Integer said it intends to use the proceeds from the sale to pay down outstanding debt and for “general corporate purposes.”
Integer Holdings Corp. is one of the largest medical device contract development and manufacturing organizations in the world. It serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
As a strategic partner of choice to medical device companies and OEMs, Integer said it’s committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. With Electrochem sold, its remaining brands include Greatbatch Medical and Lake Region Medical.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.